| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |